Apr112013
Why Does the U.S. Department of Veterans Affairs Continue to Give a Suicide–Inducing Drug to Veterans with Post Traumatic Stress Disorder?
Room 334 Cannon House Office Building Washington, DC
|
07/09/2008
Opening Statements
- Hon. Bob Filner Chairman, and a Representative in Congress from the State of California
- Hon. John T. Salazar, a Representative in Congress from the State of Colorado
- Hon. Steve Scalise, a Representative in Congress from the State of Louisiana
- Hon. Steve Buyer, Ranking Repubican Member, and a Representative in Congress from the State of Indiana
- Hon. Harry E. Mitchell, a Representative in Congress from the State of Arizona
Witnesses
Panel 1
- James G. Elliott, (Iraq War Veteran), Silver Spring, MD
- Accompanied By:
- Tammy R. Hilburn, Silver Spring, MD
- Lieutenant Colonel Roger G. Charles, USMC (Ret.), and Editor, DefenseWatch, Vice-Chairman, Board of Trustees, Soldiers for the Truth Foundation, on behalf of Eilhys England Hackworth, Chairperson, Board of Trustees, Soldiers for the Truth Foundation
Panel 2
- Hon. James B. Peake, M.D., U.S. Department of Veterans Affairs, Secretary
- Accompanied By:
- Joel Kupersmith, M.D., Veterans Health Administration, Chief Research and Development Officer, U.S. Department of Veterans Affairs
- J. Thomas Puglisi, Ph.D., CIP, Veterans Health Administration, Chief Officer, Office Research Oversight, U.S. Department of Veterans Affairs
- Miles McFall, Ph.D., Veterans Affairs Puget Sound Health Care System, Director, Post-Traumatic Stress Disorder Treatment Programs, Veterans Health Administration, U.S. Department of Veterans Affairs
- Paul Seligman, M.D., M.P.H, Center for Drug Evaluation and Research, Associate Director of Safety Policy and Communication, Food and Drug Administration, U.S. Department of Health and Human Services
- Accompanied By:
- Robert Temple, M.D., Center for Drug Evaluation and Research, Director, Office of Medical Policy, Food and Drug Administration, U.S. Department of Health and Human Services
Panel 3
- Ponni Subbiah, M.D., M.P.H., Pfizer Inc., New York, NY, Vice President, Medical Affairs
- John D. Daigh, Jr., M.D., CPA, Office of Inspector General, Assistant Inspector General for Healthcare Inspections, U.S. Department of Veterans Affairs
- Accompanied By:
- Andrea Buck, M.D., JD, Office of Healthcare Inspections, Senior Physician, Medical Consultation and Review Division, Office of Inspector General, U.S. Department of Veterans Affairs
- Randall Snow, Office of Healthcare Inspections, Associate Director, Washington, DC, Regional Office, Office of Inspector General, U.S. Department of Veterans Affairs
Sign Up for Committee Updates
Stay connected with the Committee